Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.2.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Jun. 30, 2021
Assets:    
Cash and cash equivalents $ 80,485 $ 88,322
Accounts receivable 3,793 1,170
Inventory 4,094 1,390
Other current assets 3,359 2,314
Total current assets 91,731 93,196
Property and equipment, net 51,157 30,730
Goodwill 8,051
Intangibles, net 8,994 572
Operating lease right-of-use asset, net 1,126 471
Other assets 279 25
Total Assets 161,338 124,994
Current Liabilities:    
Accounts payable and accrued expenses 11,204 6,954
Contingent Consideration 855
Operating lease liability 313 270
Deferred revenue 286 41
Total current liabilities 12,658 7,265
Long-term Liabilities:    
Convertible notes payable, net 43,731
Contingent Consideration 591
Operating lease liability 811 202
Other long-term liabilities 117 117
Total long-term liabilities 45,250 319
Total Liabilities 57,908 7,584
Commitments and Contingencies (Note 15)
Stockholders’ Equity    
Preferred Stock, par value $0.001: 5,000,000 shares authorized; none issued and outstanding
Common stock, $0.001 par value; 100,000,000 shares authorized; 57,079,347 and 51,235,764 shares issued and outstanding at June 30, 2022 and June 30, 2021, respectively 57 51
Additional paid in capital 310,171 265,130
Accumulated deficit (206,798) (147,771)
Total Stockholders’ Equity 103,430 117,410
Total Liabilities and Stockholders’ Equity $ 161,338 $ 124,994